Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Collaborative to Provide DNA-Banking Services for Drug Maker Sention

NEW YORK, Feb. 16 (GenomeWeb News) - Genomics Collaborative has signed a DNA and serum banking agreement with drug maker Sention, the companies said today.

 

Terms of the agreement call for GCI to collect serum samples, isolate DNA, and manage the data for Sention.

 

Though the pharmaceutical company focuses on memory impairment and other central nervous system disorders, the GCI deal will support "an unspecified disease state," the firms said.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.